CELLDEX THERAPEUTICS Trademark

Trademark Overview

On Wednesday, February 11, 2009, a trademark application was filed for CELLDEX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CELLDEX THERAPEUTICS trademark a serial number of 77668007. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, October 19, 2020. This trademark is owned by Celldex Therapeutics, Inc.. The CELLDEX THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Purified proteins and pharmaceuticals for therapeutic use, all for use in the treatment of cardiovascular disease, immune disorders and inflammation
celldex therapeutics

General Information

Serial Number77668007
Word MarkCELLDEX THERAPEUTICS
Filing DateWednesday, February 11, 2009
Status800 - REGISTERED AND RENEWED
Status DateMonday, October 19, 2020
Registration Number3753874
Registration DateTuesday, March 2, 2010
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 15, 2009

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Description of MarkThe mark consists of an oval design with a letter Y" inside separating the oval into three quadrants; the wording "CELLDEX" is to the right with the wording "THERAPEUTICS" below "CELLDEX".
Goods and ServicesPurified proteins and pharmaceuticals for therapeutic use, all for use in the treatment of cardiovascular disease, immune disorders and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 17, 2009
Primary Code005
First Use Anywhere DateMonday, January 12, 2009
First Use In Commerce DateMonday, January 12, 2009

Trademark Owner History

Party NameCelldex Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827
Party NameCelldex Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNeedham, MA 02494
Party NameCelldex Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNeedham, MA 02494

Trademark Events

Event DateEvent Description
Monday, October 19, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, October 19, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, October 19, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, October 19, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 31, 2020TEAS SECTION 8 & 9 RECEIVED
Saturday, March 2, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, August 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 24, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 24, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 24, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 13, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 2, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, December 15, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2009PUBLISHED FOR OPPOSITION
Monday, November 9, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 6, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 6, 2009EXAMINER'S AMENDMENT ENTERED
Friday, November 6, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 6, 2009EXAMINERS AMENDMENT E-MAILED
Friday, November 6, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, November 2, 2009EXAMINER'S AMENDMENT ENTERED
Monday, November 2, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 2, 2009EXAMINERS AMENDMENT E-MAILED
Monday, November 2, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, October 26, 2009AMENDMENT FROM APPLICANT ENTERED
Monday, October 26, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 23, 2009PAPER RECEIVED
Wednesday, May 6, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 6, 2009NON-FINAL ACTION E-MAILED
Wednesday, May 6, 2009NON-FINAL ACTION WRITTEN
Monday, May 4, 2009DATA MODIFICATION COMPLETED
Monday, May 4, 2009ASSIGNED TO LIE
Friday, May 1, 2009ASSIGNED TO EXAMINER
Wednesday, February 18, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, February 17, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 14, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics celldex disease immune disorders inflammation cardiovascular treatment proteins pharmaceuticals therapeutic purified